BR112019026846A2 - processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos - Google Patents

processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos Download PDF

Info

Publication number
BR112019026846A2
BR112019026846A2 BR112019026846-4A BR112019026846A BR112019026846A2 BR 112019026846 A2 BR112019026846 A2 BR 112019026846A2 BR 112019026846 A BR112019026846 A BR 112019026846A BR 112019026846 A2 BR112019026846 A2 BR 112019026846A2
Authority
BR
Brazil
Prior art keywords
phpl
treatment
fact
treated
platelet lysate
Prior art date
Application number
BR112019026846-4A
Other languages
English (en)
Portuguese (pt)
Inventor
David DeVos
Thier­Ry Burnouf
Jean-Christophe Deved­Jian
Ming-Li Chou
Flore GOUEL
Original Assignee
INSERM (Institut National de la Santé et de la Recherche Médicale)
Centre Hospitalier Regional Et Universitaire De Lille (Chru)
Universite De Lille
Universite Du Littoral Cote D'opale
Taipei Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INSERM (Institut National de la Santé et de la Recherche Médicale), Centre Hospitalier Regional Et Universitaire De Lille (Chru), Universite De Lille, Universite Du Littoral Cote D'opale, Taipei Medical University filed Critical INSERM (Institut National de la Santé et de la Recherche Médicale)
Publication of BR112019026846A2 publication Critical patent/BR112019026846A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/19Platelets; Megacaryocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0085Brain, e.g. brain implants; Spinal cord
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0644Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112019026846-4A 2017-06-16 2018-06-15 processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos BR112019026846A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17305739 2017-06-16
EP17305739.9 2017-06-16
PCT/EP2018/066020 WO2018229278A1 (en) 2017-06-16 2018-06-15 Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders

Publications (1)

Publication Number Publication Date
BR112019026846A2 true BR112019026846A2 (pt) 2020-06-30

Family

ID=59269973

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019026846-4A BR112019026846A2 (pt) 2017-06-16 2018-06-15 processo para preparar um lisado de plaquetas humanas agrupadas, lisado de plaquetas humanas agrupadas e seu uso para tratar transtornos neurológicos

Country Status (10)

Country Link
US (1) US11744863B2 (enExample)
EP (1) EP3638263B1 (enExample)
JP (1) JP7370870B2 (enExample)
CN (1) CN110891582A (enExample)
AU (1) AU2018284011B2 (enExample)
BR (1) BR112019026846A2 (enExample)
CA (1) CA3067294A1 (enExample)
ES (1) ES2955282T3 (enExample)
IL (1) IL271436B2 (enExample)
WO (1) WO2018229278A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
EP3920944A4 (en) * 2019-02-07 2023-03-29 Biobridge Global METHODS AND COMPOSITIONS RELATED TO PLATELET RELEASTAT AND PLATELET-RICH FIBRIN
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect
WO2023103744A1 (zh) * 2021-12-07 2023-06-15 无限发展有限公司 血小板内生长因子的提取方法
EP4276173A1 (en) 2022-05-10 2023-11-15 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Stable human platelet lysate composition, methods and uses thereof
EP4627061A1 (en) * 2022-12-02 2025-10-08 Nuwacell Biotechnologies Co., Ltd. Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
JP7731557B2 (ja) 2022-12-30 2025-09-01 スピリット サイエンティフィック カンパニー リミテッド 血小板含有組成物及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2006632A6 (es) 1987-04-21 1989-05-01 Green Cross Corp Procedimiento de tratamiento termico de fibrinogeno.
GB0512401D0 (en) * 2005-06-17 2005-07-27 Randox Lab Ltd Method
EP2069479A1 (en) * 2006-09-18 2009-06-17 Medizinische Universität Graz Plasma-free platelet lysate for use as a supplement in cell cultures and for the preparation of cell therapeutics
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
ES2402144T3 (es) * 2010-05-25 2013-04-29 Gwowei Technology Co., Ltd. Lisado plaquetario inactivado que contiene factores de crecimiento empobrecido en PDGF y VEGF y su procedimiento de preparación
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
ES2811085T7 (es) * 2011-06-27 2021-11-29 Univ Emory Composiciones, usos y preparación de lisados de plaquetas
WO2013024600A1 (ja) 2011-08-18 2013-02-21 日本電気株式会社 情報処理システム、情報処理方法、情報処理装置およびその制御方法と制御プログラム
US9867852B2 (en) * 2012-12-20 2018-01-16 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
AU2014312421A1 (en) * 2013-08-27 2016-04-14 Cook General Biotechnology Llc Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

Also Published As

Publication number Publication date
WO2018229278A1 (en) 2018-12-20
JP2020523398A (ja) 2020-08-06
US20200113942A1 (en) 2020-04-16
IL271436A (en) 2020-01-30
JP7370870B2 (ja) 2023-10-30
US11744863B2 (en) 2023-09-05
CA3067294A1 (en) 2018-12-20
EP3638263C0 (en) 2023-08-23
EP3638263B1 (en) 2023-08-23
IL271436B2 (en) 2024-02-01
ES2955282T3 (es) 2023-11-29
IL271436B1 (en) 2023-10-01
EP3638263A1 (en) 2020-04-22
CN110891582A (zh) 2020-03-17
RU2020101295A3 (enExample) 2022-02-24
RU2020101295A (ru) 2021-07-16
AU2018284011A1 (en) 2020-01-16
AU2018284011B2 (en) 2024-05-30

Similar Documents

Publication Publication Date Title
AU2018284011B2 (en) Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders
ES2545193T3 (es) Extracto de plaquetas inactivado viral, uso y preparación del mismo
AU2017238476B2 (en) Preparation of platelet pellet lysate and its use for treating neurological disorders
BR112019010228A2 (pt) processo para preparar fatores de crescimento que contêm liberado de plaquetas
CN101801397A (zh) 将治疗性细胞给予哺乳动物中枢神经系统的方法、药物组合物和制品
BR112020006316A2 (pt) processo para preparar uma fração de lisado de plaquetas, fração de lisado de plaquetas e seu uso para tratar transtornos do sistema nervoso central
Li et al. Influence of neural stem cell transplantation on angiogenesis in rats with spinal cord injury
CN102625707A (zh) Hip/pap或其衍生物的新应用
CN110755450B (zh) 间充质干细胞来源的细胞外囊泡在治疗蛛网膜下腔出血中的应用
RU2802440C2 (ru) Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений
Shi et al. Bone marrow mesenchymal stem cell exosomes alleviate oxygen-glucose deprivation/reperfusion injury in hippocampal neurons
Goczyńska et al. Innovative applications of platelet derivatives in light of information presented during the 2022 virtual congress of the International Society of Blood Transfusion (ISBT); selected issues
CN118726485A (zh) 一种过表达ho-1的神经干细胞的制备方法及用途
CN102988309B (zh) 丹酚酸a冻干粉针用于制备抑制脑组织神经元损伤或死亡药物的用途
HK1195486A (en) Viral inactivated platelet extract, use and preparation thereof

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]